A carregar...
Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib
Massimo Breccia, Giuliana AlimenaDepartment of Cellular Biotechnology and Hematology, “Sapienza” University of Rome, ItalyAbstract: The BCR-ABL kinase inhibitor imatinib mesylate is currently the standard therapy for patients with chronic myeloid leukemia (CML). Despite t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2008-10-01
|
| Colecção: | OncoTargets and Therapy |
| Acesso em linha: | http://www.dovepress.com/refining-targeted-therapies-in-chronic-myeloid-leukemia-development-an-a2488 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|